Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-04-028438
Filing Date
2004-05-27
Accepted
2004-05-27 18:40:30
Documents
2
Period of Report
2004-05-27

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bob50698jc.html 3  
1 MAIN DOCUMENT DESCRIPTION bob50698jc.xml 3 6128
2 POWER OF ATTORNEY jc-poa.txt EX-24 4557
  Complete submission text file 0001209191-04-028438.txt   12461
Mailing Address 790 MEMORIAL DR CAMBRIDGE MA 02139
Business Address 790 MEMORIAL DR CAMBRIDGE MA 02139 6172520700
ALNYLAM PHARMACEUTICALS INC (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARDINAL HEALTH PARTNERS 221 NASSAU STREET PRINCETON NJ 08542
Business Address
CLARKE JOHN K (Reporting) CIK: 0001219015 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50743 | Film No.: 04836242